Bio Solution Co (086820.KQ) Stock Price

Bio Solution Co Price

CLOSED
5,920.00
​
Market closed

Revenue has compounded at 21.5% per year over the past 10 years to 15.20 B KRW. Bio Solution Co's net margin stands at 1.8%, up from -14.3% several years earlier.

Bio Solution Co stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Bio Solution Co business model & stock analysis

Bio Solution Co. Ltd. engages in the development of cell therapy products and stem cell applied technologies based on tissue engineering and stem cell technologies. The company is headquartered in Seoul, Seoul and currently employs 96 full-time employees. The company went IPO on 2018-08-20. is a Korea based company mainly engaged in the manufacturing and distribution of cell therapy products. The firm manufactures and sells cell based cosmetic raw materials and therapeutics with background in somatic and stem cell technology. The Company’s major products include cosmetic raw material called stem water, which contains human stem cells has whitening and anti-wrinkling effects; as well as keratinocyte medication for severe burns and chondrocyte therapy product used to cure arthritis. The firm also researches and develops human tissue models for toxicity and efficacy testing using tissue engineering technology.

Frequently asked questions about Bio Solution Co

Converted at the current exchange rate, the Bio Solution Co share trades at 3.96 EUR (5,920.00 KRW).

The expected revenue of Bio Solution Co is 20.00 B KRW. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Bio Solution Co is -3.68 B KRW. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Bio Solution Co is currently -41.48. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Bio Solution Co stock.

The price-to-sales ratio (P/S) of Bio Solution Co is currently 7.64. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Bio Solution Co stock.

The Eulerpool Quality Score for Bio Solution Co is 5/10.

The ISIN of Bio Solution Co is KR7086820008. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Bio Solution Co is 086820.KQ. The ticker symbol is used to trade Bio Solution Co shares on the stock exchange.

Fair ValueTerminal
5,091.20 KRW
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Biotechnology
Number of shares
Employees
Revenue per Employee
158.33 M KRW
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
South Korea
Currency
KRW
Initial public offering
Aug 20, 2018
ISIN
KR7086820008
Cusip
Y6S78Z109
Market capitalization
142.50 B KRWLarge Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2026
-41.48
P/Ee 2027
43.85
P/Se
7.64
EV/EBIT
52.79
P/B Ratio
4.45
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
0.85 %
Last updated Oct 20, 2026, 3:08 PM

Bio Solution Co Peer Group

Bio Solution Co FIGI

086820:KS · BBG00LDPGCK7086820:KQ · BBG00LDPGCM5